The 2026 Life Sciences Industry Report: Data Complexity and AI Readiness
Life sciences organizations have never had access to more data. Pharmaceutical and biotechnology companies can now work with genomic and proteomic datasets, clinical-trial records, electronic health records, laboratory results, real-world data, manufacturing information, regulatory documents and commercial intelligence at a scale that would have been difficult to manage a decade ago. Yet data volume is…





